Literature DB >> 3166104

Physical characterization of a monoamine-sulfating form of phenol sulfotransferase from human platelets.

J A Heroux1, J A Roth.   

Abstract

The purification to homogeneity and physical characterization of a monoamine-sulfating form of phenol sulfotransferase (PST) from human platelets is described. DEAE-cellulose chromatography of a 100,000 x g supernatant solution of homogenized human platelets revealed the presence of two peaks of both dopamine- and phenol-sulfating activity, termed M- and P-PST, respectively. The latter dopamine-sulfating form eluting from the ion exchange column, MII-PST, was purified approximately 10,000-fold to electrophoretic homogeneity by Sephacryl S-200 HR and 3'-phosphoadenosine-5'-phosphate-agarose chromatography. The final specific activity of the enzyme was 930 nmol/min/mg of protein. As determined by the hydrodynamic properties of MII-PST, the native Mr was approximately 69,000. The frictional ratio (f/fo) was estimated to be 1.28, indicating that the enzyme possesses a relatively low degree of asymmetry. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis of the affinity-purified enzyme revealed the presence of single Mr species of approximately 34,000, suggesting that MII-PST exists as a homodimer in vivo. Isoelectric focusing of purified MII-PST yielded a single protein species with a pl of 4.7. The sulfhydryl-modifying reagent N-ethylmaleimide (50 microM) was found to inactivate MII-PST in a time-dependent manner. This inactivation was totally prevented by saturating concentrations of 3'-phosphoadenosine-5'-phosphosulfate, whereas dopamine bestowed only partial protection to the enzyme. These results suggest that at least one sulfhydryl moiety is present at the active site of MII-PST.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3166104

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  7 in total

1.  Reduced platelet phenolsulphotransferase activity towards dopamine and 5-hydroxytryptamine in migraine.

Authors:  A L Jones; R C Roberts; D W Colvin; G L Rubin; M W Coughtrie
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

2.  Allosteres to regulate neurotransmitter sulfonation.

Authors:  Kristie Darrah; Ting Wang; Ian Cook; Mary Cacace; Alexander Deiters; Thomas S Leyh
Journal:  J Biol Chem       Date:  2018-12-13       Impact factor: 5.157

3.  Stereoselective sulphate conjugation of salbutamol in humans: comparison of hepatic, intestinal and platelet activity.

Authors:  U K Walle; G R Pesola; T Walle
Journal:  Br J Clin Pharmacol       Date:  1993-04       Impact factor: 4.335

4.  The human phenolsulphotransferase polymorphism is determined by the level of expression of the enzyme protein.

Authors:  A L Jones; R C Roberts; M W Coughtrie
Journal:  Biochem J       Date:  1993-12-01       Impact factor: 3.857

5.  An engineered heterodimeric model to investigate SULT1B1 dependence on intersubunit communication.

Authors:  Zachary E Tibbs; Charles N Falany
Journal:  Biochem Pharmacol       Date:  2016-06-23       Impact factor: 5.858

6.  Phenolsulphotransferase: localization in kidney during human embryonic and fetal development.

Authors:  R Hume; M W Coughtrie
Journal:  Histochem J       Date:  1994-11

7.  Activation of 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b] pyridine by cDNA-expressed human and rat arylsulfotransferases.

Authors:  S Ozawa; H C Chou; F F Kadlubar; K Nagata; Y Yamazoe; R Kato
Journal:  Jpn J Cancer Res       Date:  1994-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.